Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder
Brendan Jacka, Tim Janssen, Bryan R. Garner, et al.
Drug and Alcohol Dependence (2021) Vol. 221, pp. 108617-108617
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Synthesising evidence of the effects of COVID-19 regulatory changes on methadone treatment for opioid use disorder: implications for policy
Noa Krawczyk, Bianca Rivera, Emily Levin, et al.
The Lancet Public Health (2023) Vol. 8, Iss. 3, pp. e238-e246
Open Access | Times Cited: 53
The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study
David Otiashvili, Tamar Mgebrishvili, Ada Beselia, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 39
Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020
Czarina N. Behrends, Xinlin Lu, Grace Corry, et al.
Drug and Alcohol Dependence (2022) Vol. 232, pp. 109323-109323
Open Access | Times Cited: 38
Increases in ‘deaths of despair’ during the COVID-19 pandemic in the United States and the United Kingdom
Colin Angus, Charlotte Buckley, A.M. Tilstra, et al.
Public Health (2023) Vol. 218, pp. 92-96
Open Access | Times Cited: 26
Experiences with substance use disorder treatment during the COVID-19 pandemic: Findings from a multistate survey
Brendan Saloner, Noa Krawczyk, Keisha Solomon, et al.
International Journal of Drug Policy (2021) Vol. 101, pp. 103537-103537
Open Access | Times Cited: 40
“We want everything in a one-stop shop”: acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for Black people who inject drugs
Tyler S. Bartholomew, Barbara Andraka-Cristou, Rachel Totaram, et al.
Harm Reduction Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 30
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the COVID-19 pandemic in England
Daniyar Aldabergenov, Laura Reynolds, Jenny Scott, et al.
International Journal of Drug Policy (2022) Vol. 110, pp. 103877-103877
Open Access | Times Cited: 23
The Opioid Crisis, Health, Healthcare, and Crime: A Review of Quasi-Experimental Economic Studies
Johanna Catherine Maclean, Justine Mallatt, Christopher J. Ruhm, et al.
The Annals of the American Academy of Political and Social Science (2022) Vol. 703, Iss. 1, pp. 15-49
Closed Access | Times Cited: 22
Nothing really changed: Arizona patient experience of methadone and buprenorphine access during COVID
Beth E. Meyerson, Keith Gunnar Bentele, Danielle M. Russell, et al.
PLoS ONE (2022) Vol. 17, Iss. 10, pp. e0274094-e0274094
Open Access | Times Cited: 21
Kratom Use Within the Context of the Evolving Opioid Crisis and the COVID-19 Pandemic in the United States
Walter C. Prozialeck, Peter C. Lamar, Michael Krupp, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 26
Impact of COVID-19 Pandemic on Men Who Have Sex With Men That Practice Chemsex in France: Results From the National ERAS Web Survey
Perrine Roux, Cécile Donadille, Gabriel Girard, et al.
American Journal of Men s Health (2022) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review
Siddartha Simha, Yusuf Ahmed, Chad M. Brummett, et al.
Regional Anesthesia & Pain Medicine (2022) Vol. 48, Iss. 1, pp. 37-43
Closed Access | Times Cited: 17
Exploring the impact of the COVID-19 pandemic on healthcare and substance use service access among women who inject drugs: a qualitative study
Lyra Cooper, Joseph G. Rosen, Leanne Zhang, et al.
Harm Reduction Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 8
Cause-Specific Excess Mortality in the US During the COVID-19 Pandemic
Ekaterina Degtiareva, Andrea M. Tilstra, Jonas Schöley, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Trends in opioid toxicities among people with and without opioid use disorder and the impact of the COVID-19 pandemic in Ontario, Canada: A population-based analysis
Shaleesa Ledlie, Mina Tadrous, Ahmed M. Bayoumi, et al.
International Journal of Drug Policy (2024) Vol. 127, pp. 104392-104392
Open Access | Times Cited: 2
Longitudinal trends in service utilisation of Alcohol and Other Drugs Services (AODS) during COVID-19: A Scoping Review
Hiranya Wijesundara, Tania Signal, Sanoja Pathigoda, et al.
The International Journal of Alcohol and Drug Research (2024) Vol. 12, Iss. 1, pp. 11-20
Open Access | Times Cited: 2
Illicit Substance Use and the COVID-19 Pandemic in the United States: A Scoping Review and Characterization of Research Evidence in Unprecedented Times
Anh Truc Vo, Thomas Patton, Amy Peacock, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 14, pp. 8883-8883
Open Access | Times Cited: 12
The Impact of Physicians’ COVID-19 Pandemic Occupational Experiences on Mental Health
Rebecca M. Schwartz, Molly McCann‐Pineo, Mayer Bellehsen, et al.
Journal of Occupational and Environmental Medicine (2021) Vol. 64, Iss. 2, pp. 151-157
Open Access | Times Cited: 14
Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada
Charlotte Lanièce Delaunay, Mathieu Maheu‐Giroux, Gayatri Marathe, et al.
International Journal of Drug Policy (2022) Vol. 103, pp. 103627-103627
Open Access | Times Cited: 10
The cascade of care for commercially-insured persons with opioid use disorder and comorbid HIV and HCV infections
Roman Ivasiy, Lynn M. Madden, Elizabeth DiDomizio, et al.
Drug and Alcohol Dependence (2024) Vol. 263, pp. 112410-112410
Closed Access | Times Cited: 1
Opioid Use Disorder and COVID-19: Treatment and Recovery Factors among Vulnerable Populations at the Intersection of Two U.S. Epidemics
Devin E. Banks, Maria Paschke, Xiao Li, et al.
Journal of Psychoactive Drugs (2022) Vol. 54, Iss. 4, pp. 300-308
Open Access | Times Cited: 5
Trends in deaths following drug use in England before, during, and after the COVID-19 lockdowns
Athanasios Sekeris, Thikra Algahtani, Daniyar Aldabergenov, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 2
Impact of the COVID-19 Pandemic on Infective Endocarditis Management and Outcomes: Analysis of a National Clinical Database
Alexandra Novelli, Arnar B. Ingason, Caroline Jirka, et al.
The American Journal of Cardiology (2023) Vol. 209, pp. 224-231
Closed Access | Times Cited: 2
Utilization and disparities in medication treatment for opioid use disorder among patients with comorbid opioid use disorder and chronic pain during the COVID-19 pandemic
Allison Perry, Katherine Wheeler-Martin, Deborah S. Hasin, et al.
Drug and Alcohol Dependence (2023) Vol. 253, pp. 111023-111023
Open Access | Times Cited: 2
A Framework for Developing and Assessing Custom Case Definitions: A Demonstration Applied to Opioid Overdose in Maryland
Alice Jackson, Howard Burkom
Journal of Public Health Management and Practice (2024) Vol. 30, Iss. 4, pp. 578-585
Closed Access
Page 1 - Next Page

Scroll to top